SCHEMBL7724278

SCHEMBL7724278

N=[C]CC([C]=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8863208 0.82
SCHEMBL5834996 0.69
SCHEMBL873410 0.69
SCHEMBL93745 0.65
SCHEMBL3127134 0.65
SCHEMBL1401236 0.62 CA2 (0.50)
SCHEMBL6547773 0.62 CPB2 (0.47)
SCHEMBL2385129 0.60
SCHEMBL6707281 0.60
Dichloroacetic Acid SCHEMBL28064979 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114133927-B Antibody modification method of rare earth nano probe 深圳技术大学 2023-06-13 CN claimed
CN-114133927-B Antibody modification method of rare earth nano probe 深圳技术大学 2023-06-13 CN disclosed
CN-114133927-B Antibody modification method of rare earth nano probe 深圳技术大学 2023-06-13 CN disclosed
CN-114010776-A Therapeutic immunization of HIV-infected persons for enhancing antiretroviral therapy 疫苗技术股份有限公司 2022-02-08 CN disclosed
US-6403324-B1 INCUBATING TARGET WITH AFFINITY MOLECULE CONTAINING REACTIVE FUNCTIONAL GROUP TO COVALENTLY BOND; RELEASING AFFINITY GROUP ENZYME INHIBITORS; BINDING PROTEIN AGONISTS AND ANTAGONISTS; SCREENING CONJUCHEM, INC. (CA) 2002-06-11 US disclosed
WO-1998011437-A1 AFFINITY LABELING LIBRARIES WITH TAGGED LEAVING GROUPS CONJUCHEM, INC. (CA) 1998-03-19 WO disclosed